Latest from Pharmaceuticals

'Damning' Pharmac report reveals 'fortress mentality' to decision-making

It also questions commitments to equity; just four of its nearly 150 staff are Māori.

First wahine Māori to head Pharmac advisory board

Dr Jane Thomas to lead Pharmacology and Therapeutics Advisory Committee from December.

AFT Pharmaceuticals signals future dividend as revenue, profits improve

The company will consider a dividend policy once it meets a net debt target.

Pfizer releases anti-viral pill to other makers

Health officials hope the deal could help to end the pandemic sooner.

Opinion | Give Kiwis with cystic fibrosis a future

OPINION: Christine Perrins puts the case for Pharmac to fund a life-changing treatment.

Pfizer asks US to approve vaccine for ages 5-11

Plan to ship lower-dose vials, especially marked for use in children.

Manukau supermarket among latest Auckland locations of interest

People who were at this location must isolate and get tested immediately, authorities say.

Meet Fifi, the llama whose antibodies could hold the key to fighting Covid

Coronavirus treatment made from llama nanobodies 'one of the most effective ever tested'.

Diabetes-drug decision will hit thousands, says doctor

Diabetes is the country's biggest and fastest-growing health condition.

Cecilia Robinson: Time to get serious about funding Pharmac

Pharmac now has more than $1 billion to spend every year, but it's nowhere near enough.

'Blood on my hands': Pharmac likely to end kids' cancer drug funding

Funding for drugs to help young cancer patients tipped to cease over "inconsistency".

Parents struggle to get support for daughter diagnosed with rare growth hormone disorder

Two-year-old Elenna suffers from a rare growth hormone disorder, so rare that there is no official name for it, which means no funding for drugs that can treat the condition. Video / Mark Mitchell

'I feel validated': Woman speaks after losing two babies due to 'incompetent' GP

'I had to bury two children and that's something that I don't think I will ever get over.'

Focus Live: Pharmac review to focus on speed and transparency

A review of the government's drug buyer Pharmac will focus on the timeliness and transparency of its decisions.

Dr Gary Payinda: 'If you don't want the jab, don't get it. Just stay away from patients'

Opinion: To provide a safety blanket, we need near-total coverage, with few exceptions.

Editorial: First vaccine passes muster and readied for rollout

EDITORIAL: Rollout to frontline workers and household contacts expected in first quarter.